Erythroid-specific 5-aminolevulinate synthase is stabilized by HSPA9 in mitochondrial matrix

DOI Web Site Open Access

Bibliographic Information

Other Title
  • 赤芽球特異的5-アミノレブリン酸合成酵素はミトコンドリア内でHSPA9により安定化される

Search this article

Description

In vertebrates, the rate-limiting step of heme biosynthesis is catalyzed by two isoforms of 5’- aminolevulinate synthase (ALAS) in a tissue-specific manner. The nonspecific isoform ALAS1 is expressed in all cells and undergoes heme-dependent degradation by mitochondrial matrix proteases, whereas ALAS2 is the erythroid-specific isoform that is strictly and stably expressed in erythroid cells to supply excess heme for hemoglobin production. Unlike that of ALAS1, the regulation of ALAS2 protein turnover in mitochondria has yet to be unequivocally elucidated. In this study, we found that FLAG-tagged ALAS2 (ALAS2F) expressed in a nonerythroid human cell line has a longer half-life than FLAG-tagged ALAS1, although it similarly forms complexes with mitochondrial matrix proteases under conditions of excess heme. To identify the possible proteins stabilizing ALAS2, we analyzed ALAS2F protein immunoprecipitates using mass spectrometry and identified several mitochondrial chaperone proteins, including HSPA9. Knockdown or chemical inhibition of HSPA9 caused a decrease in the ALAS2F protein level, which was assumed to result from increased degradation of ALAS2F, implying that HSPA9 plays a vital role in stabilizing the ALAS2 protein to resist degradation in the mitochondrial matrix.

Journal

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top